(S (NP (NP (DT The) (NNP Coronavirus) (NNP Disease)) (PRN (-LRB- -LRB-) (NP (NNP COVID-19)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VP (VBN affected) (NP (QP (CD 1.8) (CD million)) (NNS people))) (CC and) (VP (VBD resulted) (PP (IN in) (NP (QP (JJR more) (IN than) (CD 110,000)) (NNS deaths)))) (PP (IN as) (PP (IN of) (NP (NNP April) (CD 12) (, ,) (CD 2020)))))) (. .))
(S (NP (JJ Several) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (JJ tomographic) (NNS patterns)) (VP (VBN seen) (PP (IN on) (NP (NP (NN chest) (VBN Computed) (NNP Tomography)) (PRN (-LRB- -LRB-) (NP (NNP CT)) (-RRB- -RRB-))))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN ground-glass) (NNS opacities)) (, ,) (NP (NNS consolidations)) (, ,) (CC and) (NP (JJ crazy) (NN paving) (NN pattern)))) (, ,)) (VP (VBP are) (VP (VBN correlated) (PP (IN with) (NP (DT the) (NN disease) (NN severity) (CC and) (NN progression))))))))) (. .))
(S (NP (NNP CT) (NN imaging)) (VP (MD can) (ADVP (RB thus)) (VP (VB emerge) (PP (IN as) (NP (NP (DT an) (JJ important) (NN modality)) (PP (IN for) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NNP COVID-19) (NNS patients))))))))) (. .))
(S (NP (JJ AI-based) (NNS solutions)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (VP (TO to) (VP (VB support) (NP (ADJP (NNP CT) (VBN based)) (JJ quantitative) (NN reporting)))) (CC and) (VP (VB make) (S (NP (NN reading)) (ADJP (NN efficient) (CC and) (JJ reproducible)))))) (SBAR (IN if) (S (NP (NP (JJ quantitative) (NNS biomarkers)) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (DT the) (NN Percentage)) (PP (IN of) (NP (NNP Opacity)))) (PRN (-LRB- -LRB-) (NP (NNP PO)) (-RRB- -RRB-)) (, ,)))) (VP (MD can) (VP (VB be) (ADVP (RB automatically)) (VP (VBN computed))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NNP COVID-19)) (VP (VBZ has) (VP (VBN posed) (NP (NP (JJ unique) (NNS challenges)) (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNP AI)))))) (, ,) (S (VP (ADVP (RB specifically)) (VBG concerning) (NP (NP (DT the) (NN availability)) (PP (IN of) (NP (JJ appropriate) (NX (NX (NN image) (NNS data)) (CC and) (NX (NNS annotations))))) (PP (IN at) (NP (NN scale)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (S (VP (TO to) (VP (VB use) (NP (JJ synthetic) (NNS datasets)) (S (VP (S (VP (TO to) (VP (VB augment) (NP (DT an) (VBG existing) (JJ COVID-19) (NN database))))) (S (VP (TO to) (VP (VB tackle) (NP (DT these) (NNS challenges))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP train) (S (NP (NP (DT a) (NNP Generative) (NNP Adversarial) (NNP Network)) (PRN (-LRB- -LRB-) (NP (NNP GAN)) (-RRB- -RRB-))) (VP (TO to) (VP (VB inpaint) (NP (NNP COVID-19) (JJ related) (JJ tomographic) (NNS patterns)) (PP (IN on) (NP (JJS chest) (NN CTs))) (PP (IN from) (NP (NP (NNS patients)) (PP (IN without) (NP (JJ infectious) (NNS diseases))))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP (PRP we)) (VP (VBP leverage) (NP (NP (JJ location) (NNS priors)) (VP (VBN derived) (PP (IN from) (NP (ADJP (RB manually) (VBN labeled)) (NNP COVID-19) (NN chest) (NNP CTs) (NNS patients))))) (S (VP (TO to) (VP (VB generate) (NP (JJ appropriate) (NN abnormality) (NNS distributions)))))) (. .))
(S (NP (JJ Synthetic) (NNS data)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB improve) (NP (DT both) (NN lung) (NN segmentation) (CC and) (NX (NX (NN segmentation)) (PP (IN of) (NP (NNP COVID-19) (NNS patterns))))) (PP (IN by) (S (VP (VBG adding) (NP (NP (CD 20) (NN %)) (PP (IN of) (NP (JJ synthetic) (NNS data)))) (PP (TO to) (NP (DT the) (JJ real) (JJ COVID-19) (NN training) (NNS data))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD collected) (NP (NP (CD 2143) (NN chest) (NNP CTs)) (, ,) (VP (VBG containing) (NP (CD 327) (JJ COVID-19) (JJ positive) (NNS cases))) (, ,) (VP (VBD acquired) (PP (IN from) (NP (NP (CD 12) (NNS sites)) (PP (IN across) (NP (CD 7) (NNS countries)))))))) (. .))
(S (PP (IN By) (S (VP (VBG testing) (PP (IN on) (NP (CD 100) (UCP (ADJP (JJ COVID-19) (JJ positive)) (CC and) (NP (CD 100) (NN control))) (NNS cases)))))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (JJ synthetic) (NNS data)) (VP (MD can) (VP (VB help) (S (VP (VB improve) (NP (DT both) (NP (NP (NN lung) (NN segmentation)) (PRN (-LRB- -LRB-) (NP (ADJP (CD +6.02) (NN %)) (NN lesion) (NN inclusion) (NN rate)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ abnormality) (NN segmentation)) (PRN (-LRB- -LRB-) (NP (ADJP (CD +2.78) (NN %)) (JJ dice) (NN coefficient)) (-RRB- -RRB-)))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (DT an) (ADJP (JJ overall) (JJR more) (JJ accurate)) (NNP PO) (NN computation)) (PRN (-LRB- -LRB-) (NP (ADJP (CD +2.82) (NN %)) (NNP Pearson) (NN coefficient)) (-RRB- -RRB-))))))))))))) (. .))
